• Je něco špatně v tomto záznamu ?

Allosteric regulation of pyruvate kinase from Mycobacterium tuberculosis by metabolites

J. Snášel, I. Pichová,

. 2019 ; 1867 (2) : 125-139. [pub] 20181110

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19034906

Mycobacterium tuberculosis (Mtb) causes both acute tuberculosis and latent, symptom-free infection that affects roughly one-third of the world's population. It is a globally important pathogen that poses multiple dangers. Mtb reprograms its metabolism in response to the host niche, and this adaptation contributes to its pathogenicity. Knowledge of the metabolic regulation mechanisms in Mtb is still limited. Pyruvate kinase, involved in the late stage of glycolysis, helps link various metabolic routes together. Here, we demonstrate that Mtb pyruvate kinase (Mtb PYK) predominantly catalyzes the reaction leading to the production of pyruvate, but its activity is influenced by multiple metabolites from closely interlinked pathways that act as allosteric regulators (activators and inhibitors). We identified allosteric activators and inhibitors of Mtb PYK originating from glycolysis, citrate cycle, nucleotide/nucleoside inter-conversion related pathways that had not been described so far. Enzyme was found to be activated by fructose-1,6-bisphosphate, ribose-5-phosphate, adenine, adenosine, hypoxanthine, inosine, L-2-phosphoglycerate, l-aspartate, glycerol-2-phosphate, glycerol-3-phosphate. On the other hand thiamine pyrophosphate, glyceraldehyde-3-phosphate and L-malate were identified as inhibitors of Mtb PYK. The detailed kinetic analysis indicated a morpheein model of Mtb PYK allosteric control which is strictly dependent on Mg2+ and substantially increased by the co-presence of Mg2+ and K+.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034906
003      
CZ-PrNML
005      
20191010120645.0
007      
ta
008      
191007s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bbapap.2018.11.002 $2 doi
035    __
$a (PubMed)30419357
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Snášel, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague 166 10, Czech Republic.
245    10
$a Allosteric regulation of pyruvate kinase from Mycobacterium tuberculosis by metabolites / $c J. Snášel, I. Pichová,
520    9_
$a Mycobacterium tuberculosis (Mtb) causes both acute tuberculosis and latent, symptom-free infection that affects roughly one-third of the world's population. It is a globally important pathogen that poses multiple dangers. Mtb reprograms its metabolism in response to the host niche, and this adaptation contributes to its pathogenicity. Knowledge of the metabolic regulation mechanisms in Mtb is still limited. Pyruvate kinase, involved in the late stage of glycolysis, helps link various metabolic routes together. Here, we demonstrate that Mtb pyruvate kinase (Mtb PYK) predominantly catalyzes the reaction leading to the production of pyruvate, but its activity is influenced by multiple metabolites from closely interlinked pathways that act as allosteric regulators (activators and inhibitors). We identified allosteric activators and inhibitors of Mtb PYK originating from glycolysis, citrate cycle, nucleotide/nucleoside inter-conversion related pathways that had not been described so far. Enzyme was found to be activated by fructose-1,6-bisphosphate, ribose-5-phosphate, adenine, adenosine, hypoxanthine, inosine, L-2-phosphoglycerate, l-aspartate, glycerol-2-phosphate, glycerol-3-phosphate. On the other hand thiamine pyrophosphate, glyceraldehyde-3-phosphate and L-malate were identified as inhibitors of Mtb PYK. The detailed kinetic analysis indicated a morpheein model of Mtb PYK allosteric control which is strictly dependent on Mg2+ and substantially increased by the co-presence of Mg2+ and K+.
650    _2
$a alosterická regulace $x fyziologie $7 D000494
650    _2
$a katalýza $7 D002384
650    _2
$a glykolýza $x fyziologie $7 D006019
650    _2
$a kinetika $7 D007700
650    _2
$a metabolomika $x metody $7 D055432
650    _2
$a Mycobacterium tuberculosis $x enzymologie $x metabolismus $7 D009169
650    _2
$a pyruvátkinasa $x metabolismus $7 D011770
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pichová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague 166 10, Czech Republic. Electronic address: iva.pichova@uochb.cas.cz.
773    0_
$w MED00007006 $t Biochimica et biophysica acta. Proteins and proteomics $x 1878-1454 $g Roč. 1867, č. 2 (2019), s. 125-139
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30419357 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191010121104 $b ABA008
999    __
$a ok $b bmc $g 1451566 $s 1073456
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 1867 $c 2 $d 125-139 $e 20181110 $i 1878-1454 $m Biochimica et biophysica acta. Proteins and proteomics $n Biochem Biophys Acta $x MED00007006
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...